| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.39 | 2e-11 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.46 | 2e-10 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.46 | 2e-10 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.43 | 3e-10 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.4 | 6e-08 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.4 | 6e-08 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.37 | 3e-07 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-05 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-05 |